Home › Teva Bolsters Injectable Portfolio With Launch Of Generic Lovenox And Generic Zyvox In The United States
 

Keywords :   


Teva Bolsters Injectable Portfolio With Launch Of Generic Lovenox And Generic Zyvox In The United States

2015-02-23 05:09:10| chemicalonline News Articles

Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, recently announced the launch of the generic equivalent of Lovenox (enoxaparin sodium injection) in seven dosage strengths in the United States

Tags: the united states portfolio

Category:Chemicals

Latest from this category

All news
12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
09.11Weekly Recap: Nippon Paint, AkzoNobel, PPG Top This Weeks Stories
Chemicals »
23.11
23.11ProjectDIVAF
23.11MtG
23.11THUNDER TRUCKS HOLLOW II 148
23.11 the Tiger 7 EP
23.11 11 LEGACY
23.11 GENOCIDE
23.11HG PART1 PART2
More »